Zentis Drugs Private Limited, a active private limited company, was established on 29 March 2010 in Ambala Cantt, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100HR2010PTC040302. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Neelam Nirankari (Director), Sanchit Sidana (Director), Surinder Pal Singh (Director). Past directors included Sanjay Kumar Sinha, Jagjit Singh, Vikas Sharma. It holds ₹2.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kuldeep Nagar Nanhera Road, Ambala Cantt, Haryana, 133001.
U24100HR2010PTC040302
040302
29 March 2010
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zentis Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neelam Nirankari | Director | 04 Jan 2014 | Current |
| Sanchit Sidana | Director | 11 Nov 2016 | Current |
| Surinder Pal Singh | Director | 04 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jun 2011 | Past |
| Pramod Abcsdd | Director | 04 Apr 2010 | Past |
| Pramod Abcsdd | Director | 04 Jun 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 06 Jan 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zentis Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.48% decrease. The company also saw a substantial fall in profitability, with a 377.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Zentis Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2014 | Icici Bank Limited | ₹2.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Zentis Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zentis Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zentis Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zentis Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Zentis Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Sanchit Sidana was appointed as a Director was appointed as a Director on 11 Nov 2016 & has been associated with this company since 9 years 18 days . was completed.
Progress on A charge with Icici Bank Limited of Rs. 2.60 M registered on 24 Jun 2014 with Charge ID 10519135 was modified on 16 Jun 2015. was documented.
A charge with Icici Bank Limited amounted to Rs. 2.60 M with Charge ID 10519135 was registered on 24 Jun 2014. was recorded as a recent event.
Neelam Nirankari was appointed as a Director was appointed as a Director on 04 Jan 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
/PRNewswire/ -- PharmaHopers, a B2B marketplace dedicated to pharmaceutical manufacturing and marketing companies, now forays in the dermatology sector by....
The CIN of Zentis Drugs Private Limited is U24100HR2010PTC040302.
Zentis Drugs Private Limited is headquartered at Kuldeep Nagar Nanhera Road, Ambala Cantt, Haryana, 133001.
Zentis Drugs Private Limited was incorporated on 29 March 2010.
The current directors of Zentis Drugs Private Limited are
The primary industry of Zentis Drugs Private Limited is Trade.
Zentis Drugs Private Limited is unlisted.
The authorized capital of Zentis Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Zentis Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX